EFSCE
CLDX icon

Enterprise Financial Services Corp (EFSC)’s Celldex Therapeutics CLDX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-90
Closed -$3K – 553
2021
Q2 		$3K Hold
90
– – ﹤0.01% 1036
2021
Q1 		$2K Hold
90
– – ﹤0.01% 1128
2020
Q4 		$2K Hold
90
– – ﹤0.01% 1075
2020
Q3 		$1K Buy
+90
New +$1.05K ﹤0.01% 1163
2016
Q1 		– Sell
-7
Closed -$2K – 1063
2015
Q4 		$2K Buy
+7
New +$1.53K ﹤0.01% 908
2015
Q3 		– Sell
-7
Closed -$3K – 1093
2015
Q2 		$3K Hold
7
– – ﹤0.01% 821
2015
Q1 		$3K Hold
7
– – ﹤0.01% 907
2014
Q4 		$2K Buy
7
+1
+17% +$249 ﹤0.01% 1010
2014
Q3 		$1K Buy
+6
New +$1.31K ﹤0.01% 1117

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s CLDX Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Celldex Therapeutics (CLDX) in Q3 2021, closing a stake of 90 shares — an estimated $3K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in CLDX in Q3 2014 and held it in 9 quarters. The position peaked at $3K in Q2 2021. 160 funds tracked by Wall St. Rank hold CLDX as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Celldex Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 90 Celldex Therapeutics shares in Q3 2021, an estimated $3K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Celldex Therapeutics in Q3 2014 and held it in 9 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Celldex Therapeutics position peaked at $3K in Q2 2021.
  • 160 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.